Open Access Green as soon as Postprint is submitted to ZB.
Binding of polystyrene and carbon black nanoparticles to blood serum proteins.
Inhal. Toxicol. 23, 468-475 (2011)
Context: Once inhaled, nanoparticles (NP) deposit on the lung surface and have first contact with the epithelial lung lining fluid (ELF) rich in proteins, which may bind to NP. Objective: In this study, we investigate the parameters that influence the binding between NP and proteins. Materials and methods: We used the proteins albumin, transferrin (TF), and apolipoprotein A-1 (all known as proteins from ELF) and different NP (polystyrene NP with negative, positive, and neutral surface coatings, Printex G and Printex 90) as models. Results: In all cases, a linear correlation of the added NP amount and the amount of bound proteins was found and was described quantitatively by binding indices. Bovine serum albumin (BSA), TF, and apo A-1 were bound to the largest extent to hydrophobic NP, which shows the extraordinary importance of the NP's surface properties. Discussion: The binding index indicates the relevance of primary particle size and surface properties, including hydrophobicity. Conclusion: Size and surface modifications of NP determine their protein binding. Our results suggest that the formation of conjugates of BSA, TF, and Apo A-1 with NP may play an important role in their translocation across the air-blood-barrier and subsequent biokinetics.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Times Cited
Scopus
Cited By
Cited By
Altmetric
2.295
0.887
31
31
Annotations
Special Publikation
Hide on homepage
Publication type
Article: Journal article
Document type
Scientific Article
Keywords
Ultrafine particles; Albumin; Identification; Size; Nanotoxicology; Transferrin; Adsorption; Model
Language
Publication Year
2011
HGF-reported in Year
2011
ISSN (print) / ISBN
0895-8378
e-ISSN
1091-7691
Journal
Inhalation Toxicology
Quellenangaben
Volume: 23,
Issue: 8,
Pages: 468-475
Publisher
Informa Healthcare
Reviewing status
Peer reviewed
Institute(s)
Institute of Lung Health and Immunity (LHI)
PSP Element(s)
G-505000-002
PubMed ID
21689008
WOS ID
WOS:000291807000003
Scopus ID
79959389580
Erfassungsdatum
2011-08-09